Loading...

There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback

Loading...
There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback - Apa khabar sahabat TIMES NEW MALAYSIA, Dalam artikel yang anda baca kali ini dengan tajuk There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback, kami telah menyediakan dengan baik untuk artikel ini anda membaca dan memuat turun maklumat di dalamnya. mudah-mudahan mengisi jawatan Artikel BOLASEPAK, Artikel NEWS, Artikel PERNIAGAAN, kita menulis ini, anda boleh memahami. Nah, selamat membaca.

Tajuk : There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback
link : There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback

lihat juga


There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback

cancer cell

GE

There have been 68 new cancer treatments approved in the past five years.

That surge in treatments is coming with a higher cost. In 2016, global spending on cancer treatments hit $113 billion — up from $107 billion in 2015, according to a report released Thursday by the QuintilesIMS Institute. Those costs are expected to hit $147 billion by 2021, slightly down from the report’s projections last year.

The $113 billion is based on what the manufacturers of cancer drugs are making when they sell to health-insurance companies, pharmacy benefits managers, and others.

“These are remarkable times,” Murray Aitken, the executive director of the Quintiles IMS Institute, told Business Insider. Aitken said there’s been an “explosion of innovation” in cancer therapies, and it’s likely going to be a while before that cools down. 

At the same time, the proportion of spending that’s gone toward the new treatments has increased. In 2016, roughly 20% of the total global spending in cancer care went to the 68 new drugs approved in the past five years, up from 10% of total spending five years ago.  

Screen Shot 2017 05 31 at 2.42.21 PM

QuintilesIMS

As these new treatments — which often have $100,000 list price tags — continue to make their way onto the market, that percentage could keep increasing. 

NOW WATCH: Doctors now say this type of cancer isn’t actually cancer — and the new classification is changing thousands of lives

Please enable Javascript to watch this video

Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.



✍ Sumber Pautan : ☕ Business InsiderBusiness Insider

Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2rdj3M0

(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!

Loading...
cancer cell

GE

There have been 68 new cancer treatments approved in the past five years.

That surge in treatments is coming with a higher cost. In 2016, global spending on cancer treatments hit $113 billion — up from $107 billion in 2015, according to a report released Thursday by the QuintilesIMS Institute. Those costs are expected to hit $147 billion by 2021, slightly down from the report’s projections last year.

The $113 billion is based on what the manufacturers of cancer drugs are making when they sell to health-insurance companies, pharmacy benefits managers, and others.

“These are remarkable times,” Murray Aitken, the executive director of the Quintiles IMS Institute, told Business Insider. Aitken said there’s been an “explosion of innovation” in cancer therapies, and it’s likely going to be a while before that cools down. 

At the same time, the proportion of spending that’s gone toward the new treatments has increased. In 2016, roughly 20% of the total global spending in cancer care went to the 68 new drugs approved in the past five years, up from 10% of total spending five years ago.  

Screen Shot 2017 05 31 at 2.42.21 PM

QuintilesIMS

As these new treatments — which often have $100,000 list price tags — continue to make their way onto the market, that percentage could keep increasing. 

NOW WATCH: Doctors now say this type of cancer isn’t actually cancer — and the new classification is changing thousands of lives

Please enable Javascript to watch this video

Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.



✍ Sumber Pautan : ☕ Business InsiderBusiness Insider

Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2rdj3M0

(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!



dengan itu Perkara There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback

yang semua artikel There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback Kali ini, diharapkan dapat memberi manfaat kepada anda semua. Okay, jumpa di lain post artikel.

Kini anda membaca artikel There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback dengan alamat pautan https://timesnewmalaysia.blogspot.com/2017/05/theres-explosion-of-innovation-in-new.html

Subscribe to receive free email updates:

0 Response to "There’s an ‘explosion of innovation’ in new cancer therapies — but it has one big drawback"

Catat Ulasan

Loading...